Large Porous Particles for Pulmonary Drug Delivery

See allHide authors and affiliations

Science  20 Jun 1997:
Vol. 276, Issue 5320, pp. 1868-1872
DOI: 10.1126/science.276.5320.1868

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


A new type of inhalation aerosol, characterized by particles of small mass density and large size, permitted the highly efficient delivery of inhaled therapeutics into the systemic circulation. Particles with mass densities less than 0.4 gram per cubic centimeter and mean diameters exceeding 5 micrometers were inspired deep into the lungs and escaped the lungs' natural clearance mechanisms until the inhaled particles delivered their therapeutic payload. Inhalation of large porous insulin particles resulted in elevated systemic levels of insulin and suppressed systemic glucose levels for 96 hours, whereas small nonporous insulin particles had this effect for only 4 hours. High systemic bioavailability of testosterone was also achieved by inhalation delivery of porous particles with a mean diameter (20 micrometers) approximately 10 times that of conventional inhaled therapeutic particles.

  • * To whom correspondence should be addressed. E-mail: dxe11{at} (D.A.E.), rlanger{at} (R.L.).

View Full Text

Stay Connected to Science